Michael Stein
Direttore/Membro del Consiglio presso RESP HEAL
Posizioni attive di Michael Stein
Società | Posizione | Inizio | Fine |
---|---|---|---|
RESP HEAL | Direttore/Membro del Consiglio | 06/04/2020 | - |
Valo Therapeutics Ltd. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 01/01/2017 | - | |
The Electives Network Ltd. | Direttore/Membro del Consiglio | - | - |
Ethanjosh Ltd. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Michael Stein
Precedenti posizioni note di Michael Stein
Società | Posizione | Inizio | Fine |
---|---|---|---|
ROQUEFORT THERAPEUTICS PLC | Direttore/Membro del Consiglio | 22/03/2021 | 23/05/2024 |
Oxstem Ltd.
Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Amministratore Delegato | 01/01/2015 | 01/03/2019 |
Presidente | 01/01/2015 | 01/03/2019 | |
Doctor Care Anywhere Ltd.
Doctor Care Anywhere Ltd. Medical/Nursing ServicesHealth Services Doctor Care Anywhere Ltd. provides healthcare services via video and phone consultation. It offers prescriptions, referrals and fit notes, health tracking, and patient record services. The company was founded by Farzad Entikabi, Michael Stein and Bayju Thakar in 2013 and is headquartered in London, the United Kingdom. | Amministratore Delegato | 01/01/2013 | 01/06/2015 |
Fondatore | 01/01/2013 | 01/06/2015 | |
Tengi Ltd.
Tengi Ltd. Internet Software/ServicesTechnology Services Tengi Ltd. develops a chat application that offers cash prizes. The private company is based in London, UK. | Direttore/Membro del Consiglio | - | - |
Valo Therapeutics Oy
Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Direttore/Membro del Consiglio | - | - |
░░░ ░░ ░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Michael Stein
University of Oxford | Doctorate Degree |
University of Cape Town | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 10 |
Australia | 2 |
Sud Africa | 2 |
Posizioni
Director/Board Member | 7 |
Chief Executive Officer | 3 |
Founder | 2 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ROQUEFORT THERAPEUTICS PLC | Health Technology |
Aziende private | 9 |
---|---|
Oxstem Ltd.
Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Health Technology |
Map of Medicine Ltd.
Map of Medicine Ltd. Commercial Printing/FormsCommercial Services Map of Medicine Ltd. publishes a web-based database of medical content. The firm offers comprehensive, evidence-based local guidance and clinical decision support at the point of care. The company was founded in 2000 and is headquartered in London, the United Kingdom. | Commercial Services |
ResApp Health Ltd.
ResApp Health Ltd. Packaged SoftwareTechnology Services ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The technology is based on a machine learning algorithm that uses sound alone without the need for additional hardware to diagnose and measure the severity of a respiratory condition. ResApp’s core technology uses sound to diagnose respiratory diseases including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease and asthma. The company was founded on September 13, 2000 by John Majewski and is headquartered in Brisbane, Australia. | Technology Services |
Valo Therapeutics Ltd. | |
Doctor Care Anywhere Ltd.
Doctor Care Anywhere Ltd. Medical/Nursing ServicesHealth Services Doctor Care Anywhere Ltd. provides healthcare services via video and phone consultation. It offers prescriptions, referrals and fit notes, health tracking, and patient record services. The company was founded by Farzad Entikabi, Michael Stein and Bayju Thakar in 2013 and is headquartered in London, the United Kingdom. | Health Services |
Valo Therapeutics Oy
Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Health Technology |
The Electives Network Ltd. | |
Ethanjosh Ltd. | |
Tengi Ltd.
Tengi Ltd. Internet Software/ServicesTechnology Services Tengi Ltd. develops a chat application that offers cash prizes. The private company is based in London, UK. | Technology Services |
- Borsa valori
- Insiders
- Michael Stein
- Esperienza